Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hay

Showing results (461-470 of 515) with videos related to

Pageof 52
Sort By:
Pediatric Research|March 1, 1995
Identification of a unique form of protein C in the ovine fetus: developmentally linked transition to the adult formM J Manco-Johnson, S Spedale, M Peters, et al.
Journal of General Internal Medicine|March 9, 2021
A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5LJoel W Hay, Cynthia L Gong, Xiayu Jiao, et al.
International Journal of Cardiology. Heart & Vasculature|March 4, 2022
Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockersLuanda Grazette, Jeffrey S Tran, Nadine K Zawadzki, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 13, 2016
Chronic anemic hypoxemia increases plasma glucagon and hepatic PCK1 mRNA in late-gestation fetal sheepChristine Culpepper, Stephanie R Wesolowski, Joshua Benjamin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonistE H Ohlstein, P Nambi, A Lago, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pigD C Underwood, S Bochnowicz, R R Osborn, et al.
JAMA|February 12, 2016
Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical TrialDaniella Meeker, Jeffrey A Linder, Craig R Fox, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.
Endocrinology|April 4, 2009
Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscleStephanie R Thorn, Timothy R H Regnault, Laura D Brown, et al.
Diabetes|September 25, 2014
Placental insufficiency decreases pancreatic vascularity and disrupts hepatocyte growth factor signaling in the pancreatic islet endothelial cell in fetal sheepPaul J Rozance, Miranda Anderson, Marina Martinez, et al.
Pageof 52

Showing results (461-470 of 515) with videos related to

Sort By:
Pageof 52
Pediatric Research|March 1, 1995
Identification of a unique form of protein C in the ovine fetus: developmentally linked transition to the adult formM J Manco-Johnson, S Spedale, M Peters, et al.
Journal of General Internal Medicine|March 9, 2021
A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5LJoel W Hay, Cynthia L Gong, Xiayu Jiao, et al.
International Journal of Cardiology. Heart & Vasculature|March 4, 2022
Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockersLuanda Grazette, Jeffrey S Tran, Nadine K Zawadzki, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 13, 2016
Chronic anemic hypoxemia increases plasma glucagon and hepatic PCK1 mRNA in late-gestation fetal sheepChristine Culpepper, Stephanie R Wesolowski, Joshua Benjamin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonistE H Ohlstein, P Nambi, A Lago, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pigD C Underwood, S Bochnowicz, R R Osborn, et al.
JAMA|February 12, 2016
Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical TrialDaniella Meeker, Jeffrey A Linder, Craig R Fox, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.
Endocrinology|April 4, 2009
Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscleStephanie R Thorn, Timothy R H Regnault, Laura D Brown, et al.
Diabetes|September 25, 2014
Placental insufficiency decreases pancreatic vascularity and disrupts hepatocyte growth factor signaling in the pancreatic islet endothelial cell in fetal sheepPaul J Rozance, Miranda Anderson, Marina Martinez, et al.
Pageof 52